EUVIMEDEUVIMED entdecken
Multizentrische Studie

Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures

Roberto H Caraballo, Gabriela Reyes Valenzuela, Sebastian Fortini, Alberto Espeche, Beatriz Gamboni, Walter Silva, Marco Semprino, Lorena Fasulo, Santiago Chacón, Adolfo Gallo, Santiago Galicchio, Pedro Cachia

Epilepsy & Behavior · 2023-06 · 143 · 109245

DOI: 10.1016/j.yebeh.2023.109245 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsy & Behavior, 2023-06. Verfasst von Roberto H Caraballo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Pediatría Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. Electronic address: rhcaraballo@arnet.com.ar. Hauptthemen laut MEDLINE: Cannabidiol, Epilepsies, Myoclonic, Epilepsy, Generalized. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This multicenter study aimed to evaluate the efficacy and tolerability of add-on cannabidiol (CBD) in treatment-resistant patients with epilepsy with myoclonic-atonic seizures (EMAtS) (n = 22) and Sturge Weber syndrome (SWS) with myoclonic-atonic seizures (n = 4). METHODS: Patients who met the diagnostic criteria of treatment-resistant EMAtS or SWS with myoclonic-atonic seizures were included. Cannabidiol was added in doses ranging from 8 to 40 mg/kg/day. Efficacy was assessed by comparing seizure frequency before and after initiating CBD therapy. Neurologic examinations, brain magnetic resonance imaging, repeated prolonged electroencephalography (EEG) and/or video-EEG recordings, and neurometabolic studies were performed in all patients, and genetic investigations in 15. RESULTS: After a mean follow-up of 19 months, 15/26 patients (57.7%) who received add-on CBD had a >50% seizure decrease; three (11.5%) became seizure-free. The remaining 11 patients (42.3%) had a 25-50% seizure reduction. Drop attacks, including myoclonic-atonic seizures and generalized tonic-clonic seizures, as well as atypical absences and nonconvulsive status epilepticus responded well to CBD. In SWS patients, focal motor seizures without consciousness impairment and focal non-motor seizures with consciousness impairment were recognized in two each; in three a 30% reduction of focal seizures was observed. Side effects were mild and did not lead to CBD discontinuation. CONCLUSION: This study evaluating the use of add-on CBD in children with EMAtS or SWS with myoclonic-atonic seizures found that 15/26 (57.7%) had a >50% seizure reduction with good tolerability; three (11.5%) became seizure-free.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolEpilepsies, MyoclonicEpilepsy, GeneralizedHumansChildSeizuresBrainElectroencephalography

Stichwörter der Autor:innen

CannabidiolDrop attacksEpilepsyMyoclonic-atonic seizuresSturge Weber syndromeTreatment-resistant

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Hospital de Pediatría Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. Electronic address: rhcaraballo@arnet.com.ar.
  • Hospital de Pediatría Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina.
  • Hospital del Niño Jesús, Tucuman, Argentina.
  • Hospital Público Materno Infantil, Salta, Argentina.
  • Hospital Pediátrico Humberto H Notti, Mendoza, Argentina.
  • Hospital Italiano, Buenos Aires, Argentina.

Zitieren

APA

Caraballo, R. H., Reyes Valenzuela, G., Fortini, S., Espeche, A., Gamboni, B., Silva, W., Semprino, M., Fasulo, L., Chacón, S., Gallo, A., Galicchio, S., & Cachia, P. (2023). Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures. Epilepsy & Behavior, 143, 109245. https://doi.org/10.1016/j.yebeh.2023.109245

Vancouver

Caraballo RH, Reyes Valenzuela G, Fortini S, Espeche A, Gamboni B, Silva W, et al. Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures. Epilepsy & Behavior. 2023;143:109245. doi:10.1016/j.yebeh.2023.109245

BibTeX
@article{Caraballo2023,
  author = {Caraballo, Roberto H and Reyes Valenzuela, Gabriela and Fortini, Sebastian and Espeche, Alberto and Gamboni, Beatriz and Silva, Walter and Semprino, Marco and Fasulo, Lorena and Chacón, Santiago and Gallo, Adolfo and Galicchio, Santiago and Cachia, Pedro},
  title = {Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures},
  journal = {Epilepsy & Behavior},
  year = {2023},
  volume = {143},
  pages = {109245},
  doi = {10.1016/j.yebeh.2023.109245}
}
Kostenlos starten →